Leonardo Jaimes, MD

All articles by Leonardo Jaimes, MD

• Study shows certain cellular markers could predict SM outcomes

  A recent study showed cellular markers CD25, CD30 and CD25 could help predict prognosis in patients with systemic mastocytosis.

• Bezuclastinib shows promise as SM treatment in early stage trial

  A clinical trial studying bezuclastinab in SM patients has shown positive preliminary results in part one of phase 2.

• SM is a major risk factor for severe sting reactions

  A recent study found that diseases such as systemic mastocytosis (SM) are a significant risk factor for adverse reactions to insect stings.

• Case study: SM patient surgery successful with CytoSorb

  A recently published case report described an SM patient who underwent surgery with the addition of CytoSorb in the bypass system.

• Patient diagnosed with both SM and myelodysplastic syndrome

  A recently published case report describes a patient with a combined diagnosis of systemic mastocytosis (SM) and myelodysplastic syndrome.

• Patient with enlarged spleen, thrombocytopenia diagnosed with SM

  A recent case report described a patient with an uncommon presentation of SM that caused diagnostic challenges and resulted in a splenectomy.

• Phase 2 trial of bezuclastinib for SM partially completed

  The phase 2 Apex trial aiming to test bezuclastinib in patients with SM, has recently completed enrollment for part one of the trial.

• Study shows link between Hymenoptera venom allergy and CMD

  A recently published study showed those with Hymenoptera venom allergy (HVA) should be screened for clonal mast cell diseases (CMD).

• Study: Specialists lack knowledge, awareness of systemic mastocytosis

  According to a recently-published article, increased knowledge and awareness of systemic mastocytosis is needed among specialists.

• Case study: SM diagnosed through CT and PET scans

  A patient was diagnosed with aggressive SM due to findings from computerized tomography (CT) and contrast-enhanced PET scans.